Holen Sie sich die Stockscreener-App
18.91
3.67%
0.67
Handel nachbörslich:
19.14
0.23
+1.22%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$18.24
Offen:
$18.39
24-Stunden-Volumen:
7.47M
Relative Volume:
1.71
Marktkapitalisierung:
$6.90B
Einnahmen:
$8.91B
Nettoeinkommen (Verlust:
$1.07B
KGV:
6.9779
EPS:
2.71
Netto-Cashflow:
$781.00M
1W Leistung:
+3.05%
1M Leistung:
+11.89%
6M Leistung:
+58.11%
1J Leistung:
+22.16%
1-Tages-Spanne:
$18.24
$19.09
1-Wochen-Bereich:
$17.70
$19.51
52-Wochen-Spanne:
$10.84
$19.51
Nov Inc Stock (NOV) Company Profile
Firmenname
Nov Inc
Sektor
Telefon
346-223-3000
Adresse
10353 RICHMOND AVE., HOUSTON, TX
Compare NOV vs SLB, BKR, HAL, FTI, TS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NOV
Nov Inc
|
18.91 | 6.65B | 8.91B | 1.07B | 781.00M | 2.71 |
|
SLB
Slb Ltd
|
50.70 | 74.03B | 35.69B | 3.45B | 4.54B | 2.3617 |
|
BKR
Baker Hughes Company
|
58.92 | 56.60B | 27.73B | 2.62B | 2.54B | 2.605 |
|
HAL
Halliburton Co
|
34.98 | 28.48B | 22.18B | 1.29B | 1.67B | 1.5088 |
|
FTI
Technipfmc Plc
|
59.06 | 22.75B | 9.81B | 952.20M | 1.54B | 2.2308 |
|
TS
Tenaris S A Adr
|
46.91 | 23.21B | 11.84B | 2.03B | 1.68B | 3.7282 |
Nov Inc Stock (NOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-04 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-07-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-03-24 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-01-15 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-06 | Herabstufung | Seaport Research Partners | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Piper Sandler | Neutral |
| 2024-11-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-10-28 | Bestätigt | TD Cowen | Buy |
| 2024-09-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-07-29 | Bestätigt | TD Cowen | Buy |
| 2024-04-29 | Bestätigt | TD Cowen | Buy |
| 2024-02-05 | Bestätigt | TD Cowen | Outperform |
| 2024-01-16 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-12-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-10-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-07-14 | Eingeleitet | CapitalOne | Equal Weight |
| 2023-01-19 | Eingeleitet | The Benchmark Company | Buy |
| 2023-01-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-09 | Eingeleitet | Raymond James | Outperform |
| 2022-11-07 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-09-30 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-25 | Eingeleitet | The Benchmark Company | Hold |
| 2022-07-29 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-02 | Hochstufung | Griffin Securities | Neutral → Buy |
| 2022-03-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-02-23 | Herabstufung | Goldman | Neutral → Sell |
| 2022-02-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-09-09 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2021-07-19 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-07-15 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-07-09 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2021-05-13 | Eingeleitet | Goldman | Neutral |
| 2021-01-21 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-01-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-01-11 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-11-10 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-10-02 | Eingeleitet | BMO Capital Markets | Underperform |
| 2020-07-29 | Bestätigt | Cowen | Outperform |
| 2020-05-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-04-14 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-04-07 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2020-04-06 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-03-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-03-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-03-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-02-19 | Herabstufung | Argus | Buy → Hold |
| 2020-02-10 | Bestätigt | Cowen | Market Perform |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2019-11-05 | Bestätigt | Cowen | Market Perform |
| 2019-10-30 | Hochstufung | Goldman | Neutral → Buy |
| 2019-09-05 | Hochstufung | Jefferies | Hold → Buy |
| 2019-08-29 | Hochstufung | Johnson Rice | Hold → Buy |
| 2019-08-12 | Hochstufung | Susquehanna | Neutral → Positive |
| 2019-07-31 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-07-31 | Hochstufung | Seaport Global Securities | Sell → Neutral |
Alle ansehen
Nov Inc Aktie (NOV) Neueste Nachrichten
NOV Inc. Balances Cash Strength With Cautious 2026 Outlook - TipRanks
Earnings Miss: NOV Inc. Missed EPS By 56% And Analysts Are Revising Their Forecasts - Yahoo Finance
NOV Q4 Earnings Call Highlights - Yahoo Finance
SIG Maintains NOV Inc(NOV.US) With Buy Rating, Raises Target Price to $21 - 富途牛牛
NOV: Analyst Stifel Raises Price Target to $21.00, Maintains Buy Rating | NOV Stock News - GuruFocus
Form N-CSRS ALLIED ASSET ADVISORS For: Nov 30 - StreetInsider
NOV Q4 Earnings Miss Estimates, Revenues Beat, Both Decrease Y/Y - Yahoo Finance
RBC Capital Maintains NOV Inc(NOV.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
NOV Inc. price target raised to $21 from $20 at Susquehanna - TipRanks
NOV Inc. price target raised to $19 from $15 at Evercore ISI - TipRanks
NOV Inc. (NYSE:NOV) Q4 2025 Earnings Call Transcript - Insider Monkey
TD Cowen Maintains NOV Inc(NOV.US) With Buy Rating, Raises Target Price to $23 - 富途牛牛
NOV Q4 2025 slides reveal strong cash flow amid declining backlog and orders - Investing.com
Earnings call transcript: NOV Q4 2025 misses EPS forecast, stock falls - Investing.com India
NOV Inc. Seeks Acquisitions - marketscreener.com
NOV Inc. Reports Fourth Quarter and Full-Year 2025 Earnings - TradingView
NOV (NOV) Is Up 5.4% After Q4 Loss And Full-Year Profit SlideHas The Bull Case Changed? - Yahoo Finance
How much did the house sell for? Washington County deed transfers for Nov. 30Dec. 6, 2025 - The Herald-Mail
NOV Exceeds Revenue Expectations with Strong Q4 Performance - GuruFocus
Barclays Upgrades NOV (NOV) - Nasdaq
Nov Inc stock hits 52-week high at 19.22 USD By Investing.com - Investing.com Nigeria
NOV Inc. Forecasts Slight Revenue Decline for Q1 - GuruFocus
Nov Inc. (NOV) Q4 Earnings Lag Estimates - Yahoo Finance
NOV Inc. (NYSE:NOV) Reports Q4 2025 Revenue Beat but Significant EPS Miss - Chartmill
NOV Q4 Swings to Loss, Revenue Falls; Sets Q1 Guidance - marketscreener.com
Earnings Flash (NOV) NOV Posts Q4 EPS -$0.21, vs. FactSet Est of $0.25 - marketscreener.com
Nov Inc.: Fourth Quarter Earnings Overview - Bitget
NOV Inc (NOV) Misses Q4 EPS by 4c; offers outlook - StreetInsider
Nov Inc.: Q4 Earnings Snapshot - marketscreener.com
NOV Inc. (NOV) Upgraded by Barclays Amid Strategic Shift - GuruFocus
NOV delivers $1.25B 2025 cash flow, returns $505M to investors - stocktitan.net
NOV upgraded at Barclays as new CEO seeks portfolio reposition (NOV:NYSE) - Seeking Alpha
Beyond The Numbers: 8 Analysts Discuss NOV Stock - Benzinga
Nov earnings in spotlight as CEO Bayardo details turnaround plan - Investing.com
Nov Inc stock hits 52-week high at 19.22 USD - Investing.com
Barclays Upgrades NOV, Raises Price Target to $20 | NOV Stock Ne - GuruFocus
Barclays Upgrades NOV to Equalweight From Underweight, Raises Price Target to $20 From $15 - marketscreener.com
NOV Inc (FRA:NO8) Q4 2025 Earnings Report Preview: What To Expec - GuruFocus
Barclays Upgrades NOV Inc(NOV.US) to Hold Rating, Raises Target Price to $20 - 富途牛牛
Barclays upgrades NOV stock rating to Equalweight on new CEO vision - Investing.com
Barclays Upgrades NOV Inc. (NOV) to Equalweight - StreetInsider
What To Expect From NOV Inc (FRA:NO8) Q4 2025 Earnings - GuruFocus
300,206 Shares in NOV Inc. $NOV Bought by Keybank National Association OH - MarketBeat
New York State Common Retirement Fund Sells 217,945 Shares of NOV Inc. $NOV - MarketBeat
NOV to report Q4 earnings: What's in store for the stock? - MSN
Greenhaven Associates Inc. Grows Position in NOV Inc. $NOV - MarketBeat
Tejara Capital Ltd Acquires 166,692 Shares of NOV Inc. $NOV - MarketBeat
NOV’s Cheap Valuation Looks Hard To Ignore - Finimize
Form N-CSRS Capital Group Equity For: Nov 30 - StreetInsider
NOV to Report Q4 Earnings: What's in Store for the Stock? - Yahoo Finance
SummerHaven Investment Management LLC Buys New Position in NOV Inc. $NOV - MarketBeat
Finanzdaten der Nov Inc-Aktie (NOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):